Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Oppegard

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|April 18, 2018
Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyraseTyrell R Towle, Chaitanya A Kulkarni, Lisa M Oppegard, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2009
In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticusLisa M Oppegard, Bree L Hamann, Kathryn R Streck, et al.
Investigational New Drugs|January 10, 2009
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase IIAhad A Sadiq, Manish R Patel, Blake A Jacobson, et al.
European Journal of Pharmacology|December 17, 2008
Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase IILisa M Oppegard, Andrei V Ougolkov, Doris N Luchini, et al.
The Journal of Biological Chemistry|February 6, 2014
Fluoroquinolone-gyrase-DNA complexes: two modes of drug bindingArkady Mustaev, Muhammad Malik, Xilin Zhao, et al.
Nucleic Acids Research|March 18, 2016
Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolonesMuhammad Malik, Arkady Mustaev, Heidi A Schwanz, et al.
Investigational New Drugs|September 11, 2018
Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activityLisa M Oppegard, Justine L Delgado, Chaitanya A Kulkarni, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Bioorganic & Medicinal Chemistry Letters|April 18, 2018
Design, synthesis, and evaluation of novel N-1 fluoroquinolone derivatives: Probing for binding contact with the active site tyrosine of gyraseTyrell R Towle, Chaitanya A Kulkarni, Lisa M Oppegard, et al.
Antimicrobial Agents and Chemotherapy|March 11, 2009
In vivo and in vitro patterns of the activity of simocyclinone D8, an angucyclinone antibiotic from Streptomyces antibioticusLisa M Oppegard, Bree L Hamann, Kathryn R Streck, et al.
Investigational New Drugs|January 10, 2009
Anti-proliferative effects of simocyclinone D8 (SD8), a novel catalytic inhibitor of topoisomerase IIAhad A Sadiq, Manish R Patel, Blake A Jacobson, et al.
European Journal of Pharmacology|December 17, 2008
Novel acridine-based compounds that exhibit an anti-pancreatic cancer activity are catalytic inhibitors of human topoisomerase IILisa M Oppegard, Andrei V Ougolkov, Doris N Luchini, et al.
The Journal of Biological Chemistry|February 6, 2014
Fluoroquinolone-gyrase-DNA complexes: two modes of drug bindingArkady Mustaev, Muhammad Malik, Xilin Zhao, et al.
Nucleic Acids Research|March 18, 2016
Suppression of gyrase-mediated resistance by C7 aryl fluoroquinolonesMuhammad Malik, Arkady Mustaev, Heidi A Schwanz, et al.
Investigational New Drugs|September 11, 2018
Novel N-1 substituted fluoroquinolones inhibit human topoisomerase I activity and exhibit anti-proliferative activityLisa M Oppegard, Justine L Delgado, Chaitanya A Kulkarni, et al.
Pageof 2